Although the infrastructure required to provide image-guided therapies to treat cancer is costly, interventional oncology practices can provide radiology departments with generous revenue, according to University of Pennsylvania researchers.
Although the infrastructure required to provide image-guided therapies to treat cancer is costly, interventional oncology practices can provide radiology departments with generous revenue, according to University of Pennsylvania researchers.
Dr. Catherine Tuite and colleagues reviewed data from 1999 to 2003 for 68 patients who underwent radiofrequency ablation of liver tumors at their outpatient interventional radiology clinic.
They found that the clinic provided substantial incremental income to the general radiology practice. They presented the findings at the 2005 meeting of the Society of Interventional Radiology.
The research team included financial and marketing analysts. It recorded all aspects involved with the workup of interventional oncology patients: initial consultation, diagnostic imaging, intervention, and follow-up.
Interventional radiologists performed 100 ablations with an average professional billing of $976.77 each. Follow-up imaging included MR, CT, and plain-film radiography.
Subsequent analysis of relative value units drawn against standard payment rates from the Centers for Medicare and Medicaid Services provided the department with a total professional revenue of $7000 and $10,000 per each new ablation and chemoembolization patient, respectively.
The average revenue to the radiology practice came to above $120,000 annually, said coauthor Dr. Michael C. Soulen.
"When RFA first came out in the late 1990s, we treated about six patients with liver cancer per year. Now we treat from two to six patients per day with all interventional oncology procedures," Soulen said.
For more information from the Diagnostic Imaging archives:
Nonsurgical therapies mitigate pain from bone tumors
Lung RFA's midterm survival rates beat expectations
Insurance companies line up to reimburse for liver RFA
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.